NYSE · NUS
Consumer Defensive · Household & Personal Products
$4.65
Down-$0.04 (-0.85%)
Updated Nov 1, 2026, 5:25 PM
SID Score
3.3/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance · NUS
1M range · 20 trading sessions · Daily adjusted prices
Prices through Oct 30, 2026
NUS closed at $4.65 after 20 trading sessions, up 0.43% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 30, 2026 | $4.71 | $4.80 | $4.625 | $4.65 | 351.49K |
| Oct 29, 2026 | $4.83 | $4.86 | $4.68 | $4.69 | 253.03K |
| Oct 28, 2026 | $4.66 | $4.81 | $4.649 | $4.76 | 476.98K |
| Oct 27, 2026 | $4.72 | $4.76 | $4.61 | $4.73 | 533.93K |
| Oct 26, 2026 | $4.80 | $4.83 | $4.665 | $4.69 | 477.13K |
| Oct 23, 2026 | $4.86 | $4.895 | $4.7178 | $4.79 | 318.24K |
| Oct 22, 2026 | $4.86 | $4.97 | $4.70 | $4.92 | 271.3K |
| Oct 21, 2026 | $4.99 | $4.995 | $4.76 | $4.76 | 422.19K |
| Oct 20, 2026 | $5.02 | $5.08 | $4.97 | $4.98 | 327.61K |
| Oct 19, 2026 | $5.12 | $5.15 | $4.96 | $4.97 | 323.57K |
| Oct 16, 2026 | $5.24 | $5.39 | $5.11 | $5.14 | 572.31K |
| Oct 15, 2026 | $5.16 | $5.335 | $5.16 | $5.21 | 511.36K |
| Oct 14, 2026 | $5.03 | $5.12 | $4.985 | $5.11 | 421.39K |
| Oct 13, 2026 | $4.90 | $5.02 | $4.88 | $5.01 | 492.9K |
| Oct 12, 2026 | $4.74 | $4.92 | $4.695 | $4.87 | 590.9K |
| Oct 9, 2026 | $4.77 | $4.855 | $4.73 | $4.74 | 327.3K |
| Oct 8, 2026 | $4.80 | $4.81 | $4.705 | $4.77 | 571.4K |
| Oct 7, 2026 | $4.71 | $4.855 | $4.69 | $4.80 | 482.67K |
| Oct 6, 2026 | $4.67 | $4.795 | $4.64 | $4.74 | 405.45K |
| Oct 5, 2026 | $4.62 | $4.66 | $4.54 | $4.63 | 458.92K |
The latest Smart Investors Daily articles mentioning NUS.
Company
Market Activity
Research & News
NUS research
Company profile and research snapshot.
Nu Skin Enterprises Inc is a health and beauty direct-selling company. It has two primary product categories: beauty products and wellness products. The company develops and distributes nutritional, weight-management products, and food supplements under the Nu Skin and Pharmanex brands, respectively. The company has operations internationally, in more than 50 countries across the Americas, Europe, and the Asia-Pacific.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Dec 20, 2024 | DA Davidson | Neutral | — |
| Oct 22, 2024 | Citigroup | Neutral | — |
| Aug 12, 2024 | DA Davidson | Neutral | — |
| Aug 9, 2024 | Citigroup | Neutral | — |
| May 9, 2024 | DA Davidson | Neutral | — |
No generated briefing is available yet.
Yahoo · Oct 22, 2026
PROVO, Utah, October 22, 2026--Nu Skin Enterprises, Inc. (NYSE: NUS) today announced it will release third quarter 2026 results after the market closes on Thursday, Nov. 5. The Nu Skin management team will host a conference call with the investment community later that same day at 5 p.m. ET. During the call, management will discuss recent results and upcoming business initiatives.
SeekingAlpha · Sep 29, 2026
Nu Skin hits a 25-year low as revenue slides. See valuation metrics (P/E, EV/EBITDA, 5%+ yield) and decide if itâs a value trapâread more on NUS stock.
Yahoo · Sep 3, 2026
PROVO, Utah, September 03, 2026--Nu Skin Enterprises Inc. (NYSE: NUS), a global beauty and wellness leader, has been ranked the world’s No. 1 company for beauty and wellness device systems by Euromonitor International Ltd. for the third consecutive year.*
Fintel · Aug 28, 2026
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning NUS.
